The FDA's origins as a federal consumer protection agency began with the passage of the 1906 Pure Food and Drugs Act. For over 115 years, the agency has been responsible for regulating health and human safety for all Americans, including but not limited to the passage of the latest cancer therapeutics and diagnostics.

Testing Our Patients is a limited discussion series about how the sausage is made when bringing life-saving diagnostic tests and breakthrough medicines to cancer patients in desperate need of hope. Diverse schools of thought often collide between the risk/reward of rushing approvals too soon vs. the patient advocates who decry, "What's taking so long? We just want to live."

Testing our Patients is a product of OffScrip Health. For more information, please visit OffScrip.com.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Host Matthew Zachary, co-founder of OffScrp Health welcomes Allison Silverman, CEO of Stupid Cancer and Lizette Figueroa, Senior Director, Education & Support at The Leukemia & Lymphoma Society to discuss their work as patient advocates to get MRD testing to the patients who need them the most.

Testing Our Patients is a limited discussion series about how the sausage is made when bringing life-saving diagnostic tests and breakthrough medicines to cancer patients in desperate need of hope. Diverse schools of thought often collide between the risk/reward of rushing approvals too soon vs. the patient advocates who decry, "What's taking so long? We just want to live."

Testing our Patients is a product of OffScrip Health. For more information, please visit OffScrip.com.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Host Matt Zachery, co-founder of OffScrip Health, welcomes Dr.Rafael Fonseca and Dr.Ola Landgren in a examination of the role that doctors have advocating for MRD testing and expanding the role of diagnostics in cancer treatments

Rafael Fonseca, M.D., is the Chief Innovation Officer at Mayo clinic in Arizona.

Ola Landgren, M.D., Ph.D., is the Chief of the Myeloma Program and the Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center at the university of Miami

Testing Our Patients is a limited discussion series about how the sausage is made when bringing life-saving diagnostic tests and breakthrough medicines to cancer patients in desperate need of hope. Diverse schools of thought often collide between the risk/reward of rushing approvals too soon vs. the patient advocates who decry, "What's taking so long? We just want to live."

Testing our Patients is a product of OffScrip Health. For more information, please visit OffScrip.com.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.